Join
Live feed
·
INSIDERFilingvia Quantisnow
UroGen Pharma Ltd. logo

Smith Jason Drew sold $78,590 worth of Ordinary Shares (4,993 units at $15.74) and converted options into 10,000 units of Ordinary Shares, increasing direct ownership by 27% to 23,414 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track URGN (UroGen Pharma Ltd.) and more on Quantisnow.